https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02753-6
0
0
Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies - BMC Medicine - BMC Medicine
2/3/23 at 4:12pm
Organization
Biomedcentral.com
Authors
Details
60 words
Summarize
Endocrine Conditions Diabetes Health randomization studies Medicine Background BMC Medicine GLP-1 RAs GLP-1
Background The ability of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to decrease certain microvascular events has called for the investigation of GLP-1 RAs against diabetic retinopathy (DR), but the evidence is limited. By combining data from obser…
Create an account or login to join the discussion